485 related articles for article (PubMed ID: 29980843)
1. Contribution of toxic shock syndrome toxin-1 to systemic inflammation investigated by a mouse model of cervicovaginal infection with Staphylococcus aureus.
Asano K; Narita K; Hirose S; Nakane A
Med Microbiol Immunol; 2018 Nov; 207(5-6):297-306. PubMed ID: 29980843
[TBL] [Abstract][Full Text] [Related]
2. Vaccination with plasmid DNA encoding a mutant toxic shock syndrome toxin-1 ameliorates toxin-induced lethal shock in mice.
Feng MH; Cui JC; Nakane A; Hu DL
Tohoku J Exp Med; 2013 Sep; 231(1):1-8. PubMed ID: 23985881
[TBL] [Abstract][Full Text] [Related]
3. Toxic Shock Syndrome Toxin 1 Evaluation and Antibiotic Impact in a Transgenic Model of Staphylococcal Soft Tissue Infection.
Sharma H; Turner CE; Siggins MK; El-Bahrawy M; Pichon B; Kearns A; Sriskandan S
mSphere; 2019 Oct; 4(5):. PubMed ID: 31597722
[TBL] [Abstract][Full Text] [Related]
4. Toxicity of recombinant toxic shock syndrome toxin 1 and mutant toxins produced by Staphylococcus aureus in a rabbit infection model of toxic shock syndrome.
Bonventre PF; Heeg H; Cullen C; Lian CJ
Infect Immun; 1993 Mar; 61(3):793-9. PubMed ID: 8432600
[TBL] [Abstract][Full Text] [Related]
5. In vitro studies of toxic shock toxin-1-secreting Staphylococcus aureus and implications for burn care in children.
Laabei M; Young A; Jenkins TA
Pediatr Infect Dis J; 2012 May; 31(5):e73-7. PubMed ID: 22301473
[TBL] [Abstract][Full Text] [Related]
6. Co-production of staphylococcal enterotoxin A with toxic shock syndrome toxin-1 (TSST-1) enhances TSST-1 mediated mortality in a D-galactosamine sensitized mouse model of lethal shock.
De Boer ML; Kum WW; Pang LT; Chow AW
Microb Pathog; 1999 Aug; 27(2):61-70. PubMed ID: 10458917
[TBL] [Abstract][Full Text] [Related]
7. Impact of Currently Marketed Tampons and Menstrual Cups on Staphylococcus aureus Growth and Toxic Shock Syndrome Toxin 1 Production
Nonfoux L; Chiaruzzi M; Badiou C; Baude J; Tristan A; Thioulouse J; Muller D; Prigent-Combaret C; Lina G
Appl Environ Microbiol; 2018 Jun; 84(12):. PubMed ID: 29678918
[TBL] [Abstract][Full Text] [Related]
8. Distribution and expression of toxic shock syndrome toxin 1 gene among Staphylococcus aureus isolates of toxic shock syndrome and non-toxic shock syndrome origin.
Bonventre PF; Weckbach L; Harth G; Haidaris C
Rev Infect Dis; 1989; 11 Suppl 1():S90-5. PubMed ID: 2928656
[TBL] [Abstract][Full Text] [Related]
9. Staphylococcus aureus isogenic mutant, deficient in toxic shock syndrome toxin-1 but not staphylococcal enterotoxin A production, exhibits attenuated virulence in a tampon-associated vaginal infection model of toxic shock syndrome.
De Boer ML; Kum WW; Chow AW
Can J Microbiol; 1999 Mar; 45(3):250-6. PubMed ID: 10408098
[TBL] [Abstract][Full Text] [Related]
10. Vaccination with non-toxic mutant toxic shock syndrome toxin-1 induces IL-17-dependent protection against Staphylococcus aureus infection.
Narita K; Hu DL; Asano K; Nakane A
Pathog Dis; 2015 Jun; 73(4):. PubMed ID: 25857736
[TBL] [Abstract][Full Text] [Related]
11. Epithelial proinflammatory response and curcumin-mediated protection from staphylococcal toxic shock syndrome toxin-1.
Schaefers MM; Breshears LM; Anderson MJ; Lin YC; Grill AE; Panyam J; Southern PJ; Schlievert PM; Peterson ML
PLoS One; 2012; 7(3):e32813. PubMed ID: 22431984
[TBL] [Abstract][Full Text] [Related]
12. Effect of non-absorbent intravaginal menstrual/contraceptive products on Staphylococcus aureus and production of the superantigen TSST-1.
Schlievert PM
Eur J Clin Microbiol Infect Dis; 2020 Jan; 39(1):31-38. PubMed ID: 31853743
[TBL] [Abstract][Full Text] [Related]
13. The innate immune system is activated by stimulation of vaginal epithelial cells with Staphylococcus aureus and toxic shock syndrome toxin 1.
Peterson ML; Ault K; Kremer MJ; Klingelhutz AJ; Davis CC; Squier CA; Schlievert PM
Infect Immun; 2005 Apr; 73(4):2164-74. PubMed ID: 15784559
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of recombinant SEA-TSST fusion toxoid for protection against superantigen induced toxicity in mouse model.
Reddy PN; Paul S; Sripathy MH; Batra HV
Toxicon; 2015 Sep; 103():106-13. PubMed ID: 26091873
[TBL] [Abstract][Full Text] [Related]
15. [Correlation in Staphylococcus aureus infections between toxic shock syndrome toxin-1 production and clinical feature].
Kiyota H; Ohishi Y; Onodera S; Miki K; Ueda M
Kansenshogaku Zasshi; 1998 Jun; 72(6):593-8. PubMed ID: 9695469
[TBL] [Abstract][Full Text] [Related]
16. Use of porcine vaginal tissue ex-vivo to model environmental effects on vaginal mucosa to toxic shock syndrome toxin-1.
Davis CC; Baccam M; Mantz MJ; Osborn TW; Hill DR; Squier CA
Toxicol Appl Pharmacol; 2014 Jan; 274(2):240-8. PubMed ID: 24333258
[TBL] [Abstract][Full Text] [Related]
17. Vaccination with nontoxic mutant toxic shock syndrome toxin 1 protects against Staphylococcus aureus infection.
Hu DL; Omoe K; Sasaki S; Sashinami H; Sakuraba H; Yokomizo Y; Shinagawa K; Nakane A
J Infect Dis; 2003 Sep; 188(5):743-52. PubMed ID: 12934191
[TBL] [Abstract][Full Text] [Related]
18. Mild forms of toxic shock syndrome toxin-1-mediated exanthematous disease related to Staphylococcus aureus infection.
Moriguchi N; Kano T; Yoshimatsu Y; Yanagida H
J Infect Chemother; 2016 Aug; 22(8):571-3. PubMed ID: 26923257
[TBL] [Abstract][Full Text] [Related]
19. Risk of developing toxic shock syndrome associated with toxic shock syndrome toxin 1 following nongenital staphylococcal infection.
Jacobson JA; Kasworm E; Daly JA
Rev Infect Dis; 1989; 11 Suppl 1():S8-13. PubMed ID: 2928655
[TBL] [Abstract][Full Text] [Related]
20. Vaginal community state types (CSTs) alter environmental cues and production of the
Maduta CS; McCormick JK; Dufresne K
J Bacteriol; 2024 Mar; 206(3):e0044723. PubMed ID: 38334326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]